CRP and COVID-19: Patients in the second group (receiving vitamin D after COVID-19 diagnosis) were older than in our study (85 vs. 74 years) with higher male predominance (68.7% vs. 53% in our study), and higher CRP levels (69 vs. 55 mg/L), characteristics which would not explain the lack of benefit compared to the control group.